| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | -0.037 | 0.4 |
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | 0.033 | 0.4 |
| mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | 0.027 | 0.4 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | BRD-K78574327 | CTRPv2 | pan-cancer | AAC | -0.064 | 0.4 |
| mRNA | ML258 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | 0.025 | 0.4 |
| mRNA | cyanoquinoline 11 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.4 |
| mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | 0.037 | 0.4 |
| mRNA | CCT007093 | GDSC1000 | pan-cancer | AAC | -0.028 | 0.4 |